Cargando…
Meissner awarded US$13.4mn to expand Covid-19-related capacity
Meissner Filtration Products has secured a US$13.4 million contract from the Bio-medical Advanced Research and Development Authority (BARDA) to expand the company's production capacity for products critical to Covid-19 vaccine and therapeutics manufacturing.
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205231/ http://dx.doi.org/10.1016/S1365-6937(21)00115-5 |
| _version_ | 1783708469215363072 |
|---|---|
| collection | PubMed |
| description | Meissner Filtration Products has secured a US$13.4 million contract from the Bio-medical Advanced Research and Development Authority (BARDA) to expand the company's production capacity for products critical to Covid-19 vaccine and therapeutics manufacturing. |
| format | Online Article Text |
| id | pubmed-8205231 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82052312021-06-16 Meissner awarded US$13.4mn to expand Covid-19-related capacity Filtration Industry Analyst News Meissner Filtration Products has secured a US$13.4 million contract from the Bio-medical Advanced Research and Development Authority (BARDA) to expand the company's production capacity for products critical to Covid-19 vaccine and therapeutics manufacturing. 2021-05 2021-06-15 /pmc/articles/PMC8205231/ http://dx.doi.org/10.1016/S1365-6937(21)00115-5 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | News Meissner awarded US$13.4mn to expand Covid-19-related capacity |
| title | Meissner awarded US$13.4mn to expand Covid-19-related capacity |
| title_full | Meissner awarded US$13.4mn to expand Covid-19-related capacity |
| title_fullStr | Meissner awarded US$13.4mn to expand Covid-19-related capacity |
| title_full_unstemmed | Meissner awarded US$13.4mn to expand Covid-19-related capacity |
| title_short | Meissner awarded US$13.4mn to expand Covid-19-related capacity |
| title_sort | meissner awarded us$13.4mn to expand covid-19-related capacity |
| topic | News |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205231/ http://dx.doi.org/10.1016/S1365-6937(21)00115-5 |